Josh Mandel-Brehm
Directeur/Membre du Conseil chez PROMIS NEUROSCIENCES, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Josh Mandel-Brehm
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Directeur/Membre du Conseil | 01/09/2021 | - |
| Independent Dir/Board Member | 01/09/2021 | - | |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 01/05/2017 | - |
| Directeur Général | 01/05/2017 | - | |
| President | 01/05/2017 | - | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Directeur/Membre du Conseil | 01/09/2019 | - |
| Fondateur | 01/09/2019 | - |
Historique de carrière de Josh Mandel-Brehm
Formation de Josh Mandel-Brehm
| University of Michigan | Masters Business Admin |
| Washington University in St. Louis | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Pays-Bas | 2 |
| Canada | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Health Technology |
- Bourse
- Insiders
- Josh Mandel-Brehm
- Expérience
